Habilitationsordnung der Mathematisch-Naturwissenschaftlichen Fachbereiche der Johann Wolfgang Goethe-Universität Frankfurt am Main vom 4. Februar 1992 : genehmigt durch Beschluss des Präsidiums der Johann Wolfgang Goethe-Universität Frankfurt am Main am 19. November 2013
Ordnung der Fachbereiche 13, 14 und 15 der Johann Wolfgang Goethe-Universität Frankfurt am Main für den Bachelor- und den Masterstudiengang Biophysik vom 24. Juni 2008 : genehmigt vom Präsidium in der Sitzung am 14. Mai 2013
Promotionsordnung der Mathematisch-Naturwissenschaftlichen Fachbereiche der Johann Wolfgang Goethe-Universität in Frankfurt am Main vom 26. Mai 1993 (ABL.1/94, S. 21) zuletzt geändert am 05.09.2007 (Uni-Report 13.11.2008) : genehmigt durch Beschluss des Präsidiums der Johann Wolfgang Goethe-Universität Frankfurt am Main am 27. Januar 2009 ; hier: Änderung
Habilitationsordnung der Mathematisch–Naturwissenschaftlichen Fachbereiche der Johann Wolfgang Goethe-Universität Frankfurt am Main vom 04.02.1992 (ABl. 1992, S.816 ff.), zuletzt geändert am 28. April 2002 (StAnz. 41/2003, S. 4024 – 4025) : genehmigt durch Beschluss des Präsidiums der Johann Wolfgang Goethe-Universität Frankfurt am Main am 27. Januar 2009 ; hier: Änderung bzw. Ergänzung
In silico analysis of cell cycle synchronisation effects in radiotherapy of tumour spheroids
- Abstract: Tumour cells show a varying susceptibility to radiation damage as a function of the current cell cycle phase. While this sensitivity is averaged out in an unperturbed tumour due to unsynchronised cell cycle progression, external stimuli such as radiation or drug doses can induce a resynchronisation of the cell cycle and consequently induce a collective development of radiosensitivity in tumours. Although this effect has been regularly described in experiments it is currently not exploited in clinical practice and thus a large potential for optimisation is missed. We present an agent-based model for three-dimensional tumour spheroid growth which has been combined with an irradiation damage and kinetics model. We predict the dynamic response of the overall tumour radiosensitivity to delivered radiation doses and describe corresponding time windows of increased or decreased radiation sensitivity. The degree of cell cycle resynchronisation in response to radiation delivery was identified as a main determinant of the transient periods of low and high radiosensitivity enhancement. A range of selected clinical fractionation schemes is examined and new triggered schedules are tested which aim to maximise the effect of the radiation-induced sensitivity enhancement. We find that the cell cycle resynchronisation can yield a strong increase in therapy effectiveness, if employed correctly. While the individual timing of sensitive periods will depend on the exact cell and radiation types, enhancement is a universal effect which is present in every tumour and accordingly should be the target of experimental investigation. Experimental observables which can be assessed non-invasively and with high spatio-temporal resolution have to be connected to the radiosensitivity enhancement in order to allow for a possible tumour-specific design of highly efficient treatment schedules based on induced cell cycle synchronisation.
Author Summary: The sensitivity of a cell to a dose of radiation is largely affected by its current position within the cell cycle. While under normal circumstances progression through the cell cycle will be asynchronous in a tumour mass, external influences such as chemo- or radiotherapy can induce a synchronisation. Such a common progression of the inner clock of the cancer cells results in the critical dependence on the effectiveness of any drug or radiation dose on a suitable timing for its administration. We analyse the exact evolution of the radiosensitivity of a sample tumour spheroid in a computer model, which enables us to predict time windows of decreased or increased radiosensitivity. Fractionated radiotherapy schedules can be tailored in order to avoid periods of high resistance and exploit the induced radiosensitivity for an increase in therapy efficiency. We show that the cell cycle effects can drastically alter the outcome of fractionated irradiation schedules in a spheroid cell system. By using the correct observables and continuous monitoring, the cell cycle sensitivity effects have the potential to be integrated into treatment planing of the future and thus to be employed for a better outcome in clinical cancer therapies.
Analysis of a hybrid TATA box binding protein originating from mesophilic and thermophilic donor organisms
- The TATA Box Binding Protein (TBP) is a 20 kD protein that is essential and universally conserved in eucarya and archaea. Especially among archaea, organisms can be found that live below 0°C as well as organisms that grow above 100°C. The archaeal TBPs show a high sequence identity and a similar structure consisting of α-helices and β-sheets that are arranged in a saddle-shape 2-symmetric fold. In previous studies, we have characterized the thermal stability of thermophilic and mesophilic archaeal TBPs by infrared spectroscopy and showed the correlation between the transition temperature (Tm) and the optimal growth temperature (OGT) of the respective donor organism. In this study, a “new” mutant TBP has been constructed, produced, purified and analyzed for a deeper understanding of the molecular mechanisms of thermoadaptation. The β-sheet part of the mutant consists of the TBP from Methanothermobacter thermoautotrophicus (OGT 65°C, MtTBP65) whose α-helices have been exchanged by those of Methanosarcina mazei (OGT 37°C, MmTBP37). The Hybrid-TBP irreversibly aggregates after thermal unfolding just like MmTBP37 and MtTBP65, but the Tm lies between that of MmTBP37 and MtTBP65 indicating that the interaction between the α-helical and β-sheet part of the TBP is crucial for the thermal stability. The temperature stability is probably encoded in the variable α-helices that interact with the highly conserved and DNA binding β-sheets.